No evidence supports the commercial subcutaneous route evaluated by FDA
Kazakova TB, Barabanova SV, Khavinson VKh, Glushikhina MS, Parkhomenko EP, Malinin VV, et al
This study was partly supported by ACT-X (for K.K., JPMJAX1915 from Japan Science and Technology Agency), KAKENHI (18K14281 for K.K
BPC-157 has also demonstrated promise in supporting gut health by protecting the stomach and intestinal lining, and is studied for its roles in cytoprotection, vascular integrity, and tissue repair pathways
As research continues, studies aim to better understand BPC-157s mechanisms of action and its potential in regenerative science
Injectable BPC-157 is administered subcutaneously (under the skin) near an injury, allowing it to act directly on that specific tissue for localized repair